Shiyu Capital Overview
- Investor Type
-
Venture Capital
- Investments
-
37
- Portfolio
-
22
- Exits
-
9
Shiyu Capital General Information
Company Description
Founded in September 2014, Shiyu Capital is an asset manager and an early stage venture capital firm based in Beijing, China. The firm seeks to make investments in the pharmaceutical and healthcare industry with focus areas in biotechnology, IVD, medical services, and drug development.
Business Details
Website
www.shiyucapital.comYear Founded
Primary Investor Type
Other Investor Types
Corporate Office
- Suite 1006-1008, West Tower, QihaoBuilding
- No. 8 Xinyuan South Road, Chaoyang District
- Beijing
- China
Shiyu Capital Investments (37)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
K-Cell Biotech | 28-Oct-2022 | Later Stage VC | Biotechnology | Generating Revenue | ||
NeutanPharma | 03-Jan-2022 | 00000 00000 | Drug Discovery | Generating Revenue | ||
Stem Excel (China) | 20-Dec-2021 | 00 000000000 | Practice Management (Healthcare) | Generating Revenue | ||
UP3D | 17-Dec-2021 | 00000 00000 | 000.00 | Medical Supplies | Generating Revenue | |
GloriousMed | 01-Nov-2021 | 00000 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | |
Dical Medical | 24-Aug-2021 | 00000 00000 | Therapeutic Devices | Generating Revenue | 0000 000 | |
Intellective Bio | 24-Aug-2021 | 00000 00000 | BPO/Outsource Services | Profitable | ||
OnQuality Pharmaceuticals | 31-Mar-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | |
Biotheus | 03-Mar-2021 | Early Stage VC | Biotechnology | Generating Revenue | ||
WuXi Diagnostics | 24-Feb-2021 | Early Stage VC | 00000 | Discovery Tools (Healthcare) | Generating Revenue |
Shiyu Capital Exits (9)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Lepu Biopharma | 23-Feb-2022 | IPO | 00000 |
Mabwell | 18-Jan-2022 | 000 | 00000 |
CARsgen Therapeutics | 17-Jun-2021 | 000 | 00000 |
Jacobio Pharmaceuticals | 21-Dec-2020 | 000 | 00000 |
Allist Pharmaceuticals | 02-Dec-2020 | 000 | 00000 |
JW Therapeutics | 03-Nov-2020 | 000 | 00000 |
HitGen | 16-Apr-2020 | IPO | 00000 |
Ascentage Pharma | 28-Oct-2019 | IPO | 000.00 |
Shiyu Capital Investments by Industry, Year, and Region
Shiyu Capital Management, Team & Partners (2)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Hongbing Yang | Founding Partner | 0 | 0 | Beijing, China | |
Jian Cao | Founding Partner | 0 | 0 | Beijing, China |
Shiyu Capital Co-Investors (57)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
BioTrack Capital | 2 | ||||
Legend Capital | 0 | ||||
Lilly Asia Ventures | 0 | 0 | |||
Loyal Valley Capital | 0 | 0 | 0 | ||
Zhuhai Huajin Capital | 0 | 0 |
Shiyu Capital FAQs
-
What is Shiyu Capital?
Founded in September 2014, Shiyu Capital is an asset manager and an early stage venture capital firm based in Beijing, China.
-
When was Shiyu Capital founded?
Shiyu Capital was founded in 2014.
-
Who is the founder of Shiyu Capital?
Hongbing Yang and Jian Cao are the founders of Shiyu Capital.
-
Where is Shiyu Capital headquartered?
Shiyu Capital is headquartered in Beijing, China.
-
What is Shiyu Capital's total asset value?
Shiyu Capital has around 00000 in total assets under management.
-
How many investments has Shiyu Capital made?
Shiyu Capital has made 37 investments.
-
What has Shiyu Capital invested in?
Shiyu Capital has made numerous investments in companies like K-Cell Biotech, NeutanPharma, and Stem Excel (China) within the Biotechnology, Drug Discovery, and Practice Management (Healthcare) industries.
-
What has Shiyu Capital invested in recently?
Shiyu Capital's latest investment was on 28-Oct-2022 in K-Cell Biotech, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »